September 15, 2010 8:59 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Savient Pharmaceuticals Inc (NASDAQ: SVNT) rose 27.37% to $18.80 in the pre-market session. FDA has approved SVNT's gout drug for adults who were not getting any results from the conventional therapy. Cypress Bioscience Inc (NASDAQ: CYPB) added 13.39% to $3.98 in the pre-market session. Ramius Value and Opportunity Advisors LLC initiated an offer to buy all the outstanding shares of CYPB at $4.25 per share.UTStarcom Inc (NASDAQ: UTSI) moved up 7.25% to $2.07 in the pre-market session. UTSI has won the bid for the Equipment Purchase Project of Jinan Radio & TV Network Center, thereby becoming the exclusive broadband solution provider of the Center.Novell Inc (NASDAQ: NOVL) soared 5.03% to $5.85 in the pre-market trading. NOVL's trailing-twelve-month gross margin is 78.54%.Read more
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.